+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Genetic Testing Market by Product, Test Type, Technology, Application, Distribution Channel, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904587
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Genetic Testing Market grew from USD 11.89 billion in 2023 to USD 13.55 billion in 2024. It is expected to continue growing at a CAGR of 14.01%, reaching USD 29.79 billion by 2030.

The scope of genetic testing revolves around identifying changes in chromosomes, genes, or proteins to detect potential genetic disorders or predispositions to diseases. Its definition encompasses tests that can confirm or rule out a suspected genetic condition, helping to determine a person's chance of developing or passing on a genetic disorder. The necessity of genetic testing is underscored by its role in personalized medicine, enabling tailored healthcare strategies. The applications include prenatal screening, newborn screening, carrier testing, predictive and presymptomatic testing, and pharmacogenomics among others. End-use spans across healthcare settings such as hospitals and diagnostic labs, plus research institutions and direct-to-consumer testing services. Market growth is driven by factors like increasing prevalence of genetic disorders, heightened awareness of genomic studies, advancements in gene-editing technologies, and a growing demand for personalized medicine. The latest opportunities lie in the expansion of direct-to-consumer products and integration of AI to enhance data analysis precision. It is vital to capitalize on these by collaborating with tech firms to develop robust, user-friendly platforms. However, market constraints include stringent regulatory frameworks, ethical concerns, high costs, and a lack of skilled professionals proficient in genetic data analysis. Overcoming these challenges entails improving regulatory compliance understanding and promoting genetic counseling services. Innovators should focus on research areas such as integrating blockchain for secure data sharing, developing more efficient genome sequencing technologies, and advancing CRISPR applications. The genetic testing market is dynamic, exhibiting rapid innovation and competition. Companies must prioritize flexible strategies to adapt quickly to technology advancements and regulatory changes, while expanding outreach to untapped markets through educational initiatives to foster better understanding and acceptance among potential consumers. By aligning with key stakeholders such as healthcare providers and regulatory bodies, businesses can both drive and sustain market growth.

Understanding Market Dynamics in the Genetic Testing Market

The Genetic Testing Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Prevalence of genetic and oncology disorders and the need for precision medicine
    • Government initiatives for genetic testing and the rise of self-test kits
  • Market Restraints
    • Concerns associated with false positives and negatives of genetic tests
  • Market Opportunities
    • Ongoing research and new developments in genetic testing technologies
    • Emergence of genetic testing with telehealth and digital health platforms
  • Market Challenges
    • Logistical barriers and privacy concerns to genetic testing

Exploring Porter’s Five Forces for the Genetic Testing Market

Porter’s Five Forces framework further strengthens the insights of the Genetic Testing Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Genetic Testing Market

External macro-environmental factors deeply influence the performance of the Genetic Testing Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Genetic Testing Market

The Genetic Testing Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Genetic Testing Market

The Genetic Testing Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Genetic Testing Market

The Genetic Testing Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genetic Testing Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Agilent Technologies, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, Bruker Corporation, Centogene N.V., Color Health, Inc., CooperSurgical Inc., Editas Medicine, Inc., Eugene Labs Pty Ltd., Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fulgent Genetics, Inc., Gene by Gene, Ltd., GeneDx, LLC, Illumina, Inc., Invitae Corporation, Laboratory Corporation of America Holdings, Living DNA Ltd., Macrogen, Inc., MyHeritage Ltd., Myriad Genetics, Inc., Natera, Inc., Newtopia Inc., PathogenDx Corporation, PerkinElmer Inc., Qiagen N.V., Quest Diagnostics Incorporated, Sanofi S.A., and Thermo Fisher Scientific Inc..

Market Segmentation & Coverage

This research report categorizes the Genetic Testing Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Product
    • Consumables & Equipment
    • Software & Services
  • Test Type
    • Carrier Testing
    • Diagnostic Testing
    • New Born Screening
    • Pharmacogenomics
    • Preimplantation Testing
    • Prenatal Testing
    • Presymptomatic & Predictive Testing
  • Technology
    • Cytogenetics
    • DNA Sequencing
    • Gene Expression Profiling
    • Microarrays
    • PCR
  • Application
    • Autoimmune Disorders
    • Cancer
    • Chronic Diseases
    • Genetic Disorders
    • Neurodegenerative Diseases
  • Distribution Channel
    • Offline
    • Online
  • End-User
    • Diagnostic Laboratories
    • Home Setting
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Prevalence of genetic and oncology disorders and the need for precision medicine
5.1.1.2. Government initiatives for genetic testing and the rise of self-test kits
5.1.2. Restraints
5.1.2.1. Concerns associated with false positives and negatives of genetic tests
5.1.3. Opportunities
5.1.3.1. Ongoing research and new developments in genetic testing technologies
5.1.3.2. Emergence of genetic testing with telehealth and digital health platforms
5.1.4. Challenges
5.1.4.1. Logistical barriers and privacy concerns to genetic testing
5.2. Market Segmentation Analysis
5.2.1. Product: Penetration of software and services for efficient data management and analysis
5.2.2. Test Type: Emphasis on diagnostic testing to perform a particular disease diagnosis
5.2.3. Technology: Increasing shift toward DNA sequencing for precise gene identification and disease diagnosis
5.2.4. Application: Rising adoption of genetic testing to detect early signs of cancer
5.2.5. Distribution Channel: Deployment of genetic testing products on online platforms
5.2.6. End-User: Extensive use of genetic testing solutions in hospitals & clinics for disease diagnosis and treatment planning
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Genetic Testing Market, by Product
6.1. Introduction
6.2. Consumables & Equipment
6.3. Software & Services
7. Genetic Testing Market, by Test Type
7.1. Introduction
7.2. Carrier Testing
7.3. Diagnostic Testing
7.4. New Born Screening
7.5. Pharmacogenomics
7.6. Preimplantation Testing
7.7. Prenatal Testing
7.8. Presymptomatic & Predictive Testing
8. Genetic Testing Market, by Technology
8.1. Introduction
8.2. Cytogenetics
8.3. DNA Sequencing
8.4. Gene Expression Profiling
8.5. Microarrays
8.6. PCR
9. Genetic Testing Market, by Application
9.1. Introduction
9.2. Autoimmune Disorders
9.3. Cancer
9.4. Chronic Diseases
9.5. Genetic Disorders
9.6. Neurodegenerative Diseases
10. Genetic Testing Market, by Distribution Channel
10.1. Introduction
10.2. Offline
10.3. Online
11. Genetic Testing Market, by End-User
11.1. Introduction
11.2. Diagnostic Laboratories
11.3. Home Setting
11.4. Hospitals & Clinics
12. Americas Genetic Testing Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific Genetic Testing Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa Genetic Testing Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. Market Share Analysis, 2023
15.2. FPNV Positioning Matrix, 2023
15.3. Competitive Scenario Analysis
15.3.1. Sysmex and QIAGEN strengthen alliance to advance genetic testing innovation
15.3.2. Labcorp Finalizes Acquisition of Key Invitae Assets in Strategic Expansion
15.3.3. Labcorp and Ultima Genomics partnership advances affordable genomic insights for oncology testing
15.3.4. MedGenome expands its influence through strategic acquisition in east India’s genetic testing landscape
15.3.5. Bruker Corporation Expanded Diagnostic Capabilities with EUR 870 Million Acquisition of ELITechGroup SAS, Enhancing Molecular and Microbial Testing
15.3.6. Devyser AB Unveiled New Genetic Testing Products to Improve Cancer Risk Analysis
15.3.7. Blueprint Genetics Oy Offers Advanced Testing Solutions for Informed Family Planning Decisions
15.3.8. Kindbody Unveiled Affordable, High-Quality Genetic Testing Division Kindlabs for Enhanced Pregnancy Success
15.3.9. Delve Bio, Inc. Secureed USD 35 Million Funding to Unveil Causes of Neurological Inflammation Through Advanced Pathogen Detection
15.3.10. FBI Approved QIAGEN N.V.'s Advanced Forensic DNA Testing Workflow for Use in National Crime Database
15.3.11. healthOme, Inc. Acquired Kailos Genetics, Inc., to Enhance Genetic Testing Services for Cancer Risk and Medication Safety
15.3.12. BeautyMap Launched DNA-Based Skincare and Haircare Test In India
15.3.13. CENTOGENE N.V. and Takeda Pharmaceutical Company Limited Extend Partnership to Enhance Diagnostic Testing for Rare Diseases Globally
15.3.14. Invitae Corporation and Epic Systems Corporation Joined Forces to Streamline Genetic Test Results, Enhancing Access for Healthcare Providers
15.3.15. Agilent Technologies Inc. Expanded Clinical Research Capabilities with Acquisition of Avida Biomed
15.4. Strategy Analysis & Recommendation
15.4.1. Natera, Inc.
15.4.2. F. Hoffmann-La Roche AG
15.4.3. Thermo Fisher Scientific Inc.
15.4.4. Illumina, Inc.
List of Figures
FIGURE 1. GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. GENETIC TESTING MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
FIGURE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
FIGURE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 21. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 23. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 26. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 27. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GENETIC TESTING MARKET DYNAMICS
TABLE 7. GLOBAL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL GENETIC TESTING MARKET SIZE, BY CONSUMABLES & EQUIPMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL GENETIC TESTING MARKET SIZE, BY SOFTWARE & SERVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL GENETIC TESTING MARKET SIZE, BY CARRIER TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL GENETIC TESTING MARKET SIZE, BY NEW BORN SCREENING, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL GENETIC TESTING MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL GENETIC TESTING MARKET SIZE, BY PRENATAL TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL GENETIC TESTING MARKET SIZE, BY PRESYMPTOMATIC & PREDICTIVE TESTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL GENETIC TESTING MARKET SIZE, BY CYTOGENETICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL GENETIC TESTING MARKET SIZE, BY DNA SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL GENETIC TESTING MARKET SIZE, BY GENE EXPRESSION PROFILING, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL GENETIC TESTING MARKET SIZE, BY MICROARRAYS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL GENETIC TESTING MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL GENETIC TESTING MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL GENETIC TESTING MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL GENETIC TESTING MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL GENETIC TESTING MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL GENETIC TESTING MARKET SIZE, BY NEURODEGENERATIVE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL GENETIC TESTING MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL GENETIC TESTING MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL GENETIC TESTING MARKET SIZE, BY HOME SETTING, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL GENETIC TESTING MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. AMERICAS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 38. AMERICAS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. ARGENTINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 45. ARGENTINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 46. ARGENTINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. ARGENTINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 48. ARGENTINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 49. ARGENTINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 50. BRAZIL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 51. BRAZIL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 52. BRAZIL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 53. BRAZIL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 54. BRAZIL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 55. BRAZIL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 56. CANADA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 57. CANADA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 59. CANADA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 60. CANADA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 61. CANADA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. MEXICO GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 63. MEXICO GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 64. MEXICO GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 65. MEXICO GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 66. MEXICO GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 67. MEXICO GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 68. UNITED STATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 69. UNITED STATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 70. UNITED STATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 71. UNITED STATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 72. UNITED STATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. UNITED STATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 74. UNITED STATES GENETIC TESTING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 75. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 76. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 77. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 78. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 80. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 82. AUSTRALIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 83. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 84. AUSTRALIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. AUSTRALIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 86. AUSTRALIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 87. AUSTRALIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 88. CHINA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 89. CHINA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 90. CHINA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 91. CHINA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 92. CHINA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 93. CHINA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 94. INDIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 95. INDIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 96. INDIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 97. INDIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 98. INDIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 99. INDIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. INDONESIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 101. INDONESIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 102. INDONESIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. INDONESIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. INDONESIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 105. INDONESIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 106. JAPAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 107. JAPAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 108. JAPAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 109. JAPAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 110. JAPAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 111. JAPAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 112. MALAYSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 113. MALAYSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 114. MALAYSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 115. MALAYSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 116. MALAYSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 117. MALAYSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. PHILIPPINES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 119. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 120. PHILIPPINES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 121. PHILIPPINES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 122. PHILIPPINES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 123. PHILIPPINES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 124. SINGAPORE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 125. SINGAPORE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 126. SINGAPORE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 127. SINGAPORE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 128. SINGAPORE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 129. SINGAPORE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 131. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 132. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 133. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 134. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 135. SOUTH KOREA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. TAIWAN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 137. TAIWAN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 138. TAIWAN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 139. TAIWAN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. TAIWAN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 141. TAIWAN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 142. THAILAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 143. THAILAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 144. THAILAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 145. THAILAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 146. THAILAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 147. THAILAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 148. VIETNAM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 149. VIETNAM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 150. VIETNAM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 151. VIETNAM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 152. VIETNAM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 153. VIETNAM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 161. DENMARK GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 162. DENMARK GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 163. DENMARK GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 164. DENMARK GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. DENMARK GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 166. DENMARK GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 167. EGYPT GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 168. EGYPT GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 169. EGYPT GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 170. EGYPT GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 171. EGYPT GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 172. EGYPT GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 173. FINLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 174. FINLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 175. FINLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. FINLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 177. FINLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. FINLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 179. FRANCE GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 180. FRANCE GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 181. FRANCE GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 182. FRANCE GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 183. FRANCE GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 184. FRANCE GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 185. GERMANY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 186. GERMANY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 187. GERMANY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 188. GERMANY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 189. GERMANY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 190. GERMANY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. ISRAEL GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 192. ISRAEL GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 193. ISRAEL GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. ISRAEL GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. ISRAEL GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 196. ISRAEL GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 197. ITALY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 198. ITALY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 199. ITALY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 200. ITALY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 201. ITALY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. ITALY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 209. NIGERIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 215. NORWAY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 216. NORWAY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 217. NORWAY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 218. NORWAY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 219. NORWAY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 220. NORWAY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. POLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 222. POLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 223. POLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 224. POLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. POLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. POLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 227. QATAR GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 228. QATAR GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 229. QATAR GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. QATAR GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 231. QATAR GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 232. QATAR GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 233. RUSSIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 234. RUSSIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 235. RUSSIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 236. RUSSIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 237. RUSSIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 238. RUSSIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 239. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 240. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 241. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 242. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 243. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 244. SAUDI ARABIA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 245. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 246. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 247. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 249. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. SOUTH AFRICA GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 251. SPAIN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 252. SPAIN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 253. SPAIN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 254. SPAIN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 255. SPAIN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 256. SPAIN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 257. SWEDEN GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 258. SWEDEN GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWEDEN GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 260. SWEDEN GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 261. SWEDEN GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 262. SWEDEN GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. SWITZERLAND GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 267. SWITZERLAND GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 268. SWITZERLAND GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 269. TURKEY GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 270. TURKEY GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 271. TURKEY GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 272. TURKEY GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 273. TURKEY GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. TURKEY GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 275. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 276. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 277. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 278. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 279. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 280. UNITED ARAB EMIRATES GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 281. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
TABLE 282. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
TABLE 283. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 285. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 286. UNITED KINGDOM GENETIC TESTING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 287. GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2023
TABLE 288. GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Genetic Testing market, which are profiled in this report, include:
  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Bruker Corporation
  • Centogene N.V.
  • Color Health, Inc.
  • CooperSurgical Inc.
  • Editas Medicine, Inc.
  • Eugene Labs Pty Ltd.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche AG
  • Fulgent Genetics, Inc.
  • Gene by Gene, Ltd.
  • GeneDx, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Laboratory Corporation of America Holdings
  • Living DNA Ltd.
  • Macrogen, Inc.
  • MyHeritage Ltd.
  • Myriad Genetics, Inc.
  • Natera, Inc.
  • Newtopia Inc.
  • PathogenDx Corporation
  • PerkinElmer Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Sanofi S.A.
  • Thermo Fisher Scientific Inc.

Methodology

Loading
LOADING...

Table Information